WHO ICTRP trial
Does asthma phenotype have impact on disease control
EUCTR2013-004905-15-DK · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2013-004905-15-DK |
|---|---|
| Public title | Does asthma phenotype have impact on disease control |
| Scientific title | Does asthma phenotype have impact on disease control |
| Primary sponsor | Respiratory Research Unit, Bispebjerg Hospital |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): yes Therapeutic use (Phase IV): yes |
| Countries | Denmark |
| Conditions | Asthma MedDRA version: 16.1 Level: PT Classification code 10003553 Term: Asthma System Organ Class: 10038738 - Respiratory, thoracic and mediastinal disorders ;Therapeutic area: Body processes [G] - Circulatory and Respiratory Physiological… |
| Interventions | Trade Name: Bricanyl Pharmaceutical Form: Inhalation powder INN or Proposed INN: TERBUTALINE CAS Number: 23031-25-6 Concentration unit: 1X 100 milligrams/millilitre Concentration type: equal Concentration number: 500-500 Trade Name… |
| Registration date | Jan 22, 2014 |
| Target size | 45 |
| Secondary IDs | 2013103120 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: